Trupanion had its Relative Strength (RS) Rating upgraded from 79 to 84 Thursday.
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the market's biggest winners typically have an RS Rating of above 80 as they launch their biggest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
Trupanion is trying to complete a consolidation with a 57.90 entry. See if it can clear the breakout price in heavy trading.
Trupanion showed 0% EPS growth in the latest quarterly report, while sales growth came in at 15%. Keep an eye out for the company's next round of numbers on or around Feb. 19.
The company holds the No. 4 rank among its peers in the Insurance-Accident & Healthcare industry group. Unum Group is the No. 1-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
